HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text (PDF) All Versions of this Article: dc06-2247v1 30/5/1212    most recent Purchase Article View Shopping Cart Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Targher, G. Articles by Arcaro, G. Search for Related Content PubMed PubMed Citation Articles by Targher, G. Articles by Arcaro, G. Social Bookmarking                What's this?

Prevalence of nonalcoholic fatty liver disease and its association with cardiovascular disease among type 2 diabetic patients

¹Department of Internal Medicine, "Sacro Cuore" Hospital, Negrar (VR), Italy
²Department of Radiology, "Sacro Cuore" Hospital, Negrar (VR), Italy
³Institute of Cellular Medicine, Newcastle University, Newcastle upon Tyne, England

targher{at}sacrocuore.it

ABSTRACT

OBJECTIVE - To determine the prevalence of nonalcoholic fatty liver disease (NAFLD) in type 2 diabetic population, and to compare the prevalence of cardiovascular disease (CVD) and its risk factors between people with and without NAFLD.

RESEARCH DESIGN AND METHODS - The entire sample of type 2 diabetic outpatients (n=2,839) who regularly attended our clinic was screened. Main outcome measures were NAFLD (by patient history and liver ultrasound) and manifest CVD (by patient history, review of patient records, electrocardiogram and echo-Doppler of carotid and lower limb arteries).

RESULTS - The unadjusted prevalence of NAFLD was 69.5% among participants, and NAFLD was the most common cause (81.5%) of hepatic steatosis on ultrasound. The prevalence of NAFLD increased with age (65.4% among participants aged 40-59 years and 74.6% among those aged 60 years; p<0.001) and the age-adjusted prevalence of NAFLD was 71.1% in men and 68% in women. NAFLD patients had remarkably (p<0.001) higher age, and sex-adjusted prevalences of coronary (26.6 vs. 18.3%), cerebrovascular (20.0 vs. 13.3%) and peripheral (15.4 vs. 10.0%) vascular disease than their counterparts without NAFLD. In logistic regression analysis, NAFLD was associated with prevalent CVD independent of classical risk factors, glycaemic control, medications and the metabolic syndrome features.

CONCLUSIONS - NAFLD is extremely common in people with type 2 diabetes and is associated with higher prevalence of CVD. Follow-up studies are needed to determine whether NAFLD predicts the development and progression of CVD.

CiteULike    Del.icio.us    Digg    Reddit    Technorati    What's this?

This article has been cited by other articles:

				N. Anderson and J. Borlak Molecular Mechanisms and Therapeutic Targets in Steatosis and Steatohepatitis Pharmacol. Rev., September 1, 2008; 60(3): 311 - 357. [Abstract] [Full Text] [PDF]

				N. Stefan, K. Kantartzis, J. Machann, F. Schick, C. Thamer, K. Rittig, B. Balletshofer, F. Machicao, A. Fritsche, and H.-U. Haring Identification and Characterization of Metabolically Benign Obesity in Humans Arch Intern Med, August 11, 2008; 168(15): 1609 - 1616. [Abstract] [Full Text] [PDF]

				G. Targher, M. Chonchol, L. Bertolini, S. Rodella, L. Zenari, G. Lippi, M. Franchini, G. Zoppini, and M. Muggeo Increased Risk of CKD among Type 2 Diabetics with Nonalcoholic Fatty Liver Disease J. Am. Soc. Nephrol., August 1, 2008; 19(8): 1564 - 1570. [Abstract] [Full Text] [PDF]

				K. Kantartzis, K. Rittig, A. Cegan, J. Machann, F. Schick, B. Balletshofer, A. Fritsche, E. Schleicher, H.-U. Haring, and N. Stefan Fatty Liver Is Independently Associated With Alterations in Circulating HDL2 and HDL3 Subfractions Diabetes Care, February 1, 2008; 31(2): 366 - 368. [Full Text] [PDF]

				A. Kotronen, L. Juurinen, A. Hakkarainen, J. Westerbacka, A. Corner, R. Bergholm, and H. Yki-Jarvinen Liver Fat Is Increased in Type 2 Diabetic Patients and Underestimated by Serum Alanine Aminotransferase Compared With Equally Obese Nondiabetic Subjects Diabetes Care, January 1, 2008; 31(1): 165 - 169. [Abstract] [Full Text] [PDF]

				R. K. Schindhelm, R. J. Heine, and M. Diamant Prevalence of Nonalcoholic Fatty Liver Disease and Its Association With Cardiovascular Disease Among Type 2 Diabetic Patients: Response to Targher et al. Diabetes Care, September 1, 2007; 30(9): e94 - e94. [Full Text] [PDF]

				G. Targher, L. Bertolini, and C. Day Prevalence of Nonalcoholic Fatty Liver Disease and Its Association With Cardiovascular Disease Among Type 2 Diabetic Patients: Response to Schindhelm, Heine, and Diamant Diabetes Care, September 1, 2007; 30(9): e95 - e95. [Full Text] [PDF]

				G. Targher, L. Bertolini, S. Rodella, R. Tessari, L. Zenari, G. Lippi, and G. Arcaro Nonalcoholic Fatty Liver Disease Is Independently Associated With an Increased Incidence of Cardiovascular Events in Type 2 Diabetic Patients Diabetes Care, August 1, 2007; 30(8): 2119 - 2121. [Full Text] [PDF]

				M. Talim Prevalence of Nonalcoholic Fatty Liver Disease and Its Association With Cardiovascular Disease Among Type 2 Diabetic Patients: Response to Targher et al. and Hu et al. Diabetes Care, June 1, 2007; 30(6): e55 - e55. [Full Text] [PDF]

				G. Targher, L. Bertolini, L. Scala, L. Zenari, G. Lippi, M. Franchini, and G. Arcaro Plasma PAI-1 Levels Are Increased in Patients With Nonalcoholic Steatohepatitis Diabetes Care, May 1, 2007; 30(5): e31 - e32. [Full Text] [PDF]